{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T01:38:58Z","timestamp":1793929138208,"version":"4.8.0"},"reference-count":63,"publisher":"Impact Journals, LLC","issue":"29","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2017,7,18]]},"DOI":"10.18632\/oncotarget.17544","type":"journal-article","created":{"date-parts":[[2017,5,2]],"date-time":"2017-05-02T09:55:17Z","timestamp":1493718917000},"page":"47675-47690","source":"Crossref","is-referenced-by-count":46,"title":["Osteoclast proton pump regulator Atp6v1c1 enhances breast cancer growth by activating the mTORC1 pathway and bone metastasis by increasing V-ATPase activity"],"prefix":"10.18632","volume":"8","author":[{"given":"Matthew","family":"McConnell","sequence":"first","affiliation":[{"name":"Department of Pathology, University of Alabama at Birmingham, Birmingham, AL, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengmei","family":"Feng","sequence":"additional","affiliation":[{"name":"Department of Pathology, University of Alabama at Birmingham, Birmingham, AL, USA"},{"name":"Shanghai Institute of Traumatology and Orthopedics, Shanghai Key Laboratory for Prevention and Treatment of Bone and Joint Diseases with Integrated Chinese-Western Medicine, Ruijin Hospital, Jiao Tong University School of Medicine, Shanghai, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Pathology, University of Alabama at Birmingham, Birmingham, AL, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guochun","family":"Zhu","sequence":"additional","affiliation":[{"name":"Shanghai Institute of Traumatology and Orthopedics, Shanghai Key Laboratory for Prevention and Treatment of Bone and Joint Diseases with Integrated Chinese-Western Medicine, Ruijin Hospital, Jiao Tong University School of Medicine, Shanghai, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dejun","family":"Shen","sequence":"additional","affiliation":[{"name":"Department of Pathology, University of Alabama at Birmingham, Birmingham, AL, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Selvarangan","family":"Ponnazhagan","sequence":"additional","affiliation":[{"name":"Department of Pathology, University of Alabama at Birmingham, Birmingham, AL, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lianfu","family":"Deng","sequence":"additional","affiliation":[{"name":"Shanghai Institute of Traumatology and Orthopedics, Shanghai Key Laboratory for Prevention and Treatment of Bone and Joint Diseases with Integrated Chinese-Western Medicine, Ruijin Hospital, Jiao Tong University School of Medicine, Shanghai, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Ping","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Pathology, University of Alabama at Birmingham, Birmingham, AL, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7892","published-online":{"date-parts":[[2017,5,2]]},"reference":[{"key":"1","first-page":"443","article-title":"Structure and function of V-ATPases in osteoclasts: potential therapeutic targets for the treatment of osteolysis","volume":"22","author":"Zheng","year":"2007","journal-title":"Histol Histopathol"},{"key":"2","doi-asserted-by":"crossref","first-page":"12951","DOI":"10.1074\/jbc.274.19.12951","article-title":"Structure and properties of the vacuolar (H+)-ATPases","volume":"274","author":"Forgac","year":"1999","journal-title":"J Biol Chem"},{"key":"3","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1038\/nrm2272","article-title":"Vacuolar ATPases: rotary proton pumps in physiology and pathophysiology","volume":"8","author":"Forgac","year":"2007","journal-title":"Nat Rev Mol Cell Biol"},{"key":"4","doi-asserted-by":"crossref","first-page":"28909","DOI":"10.1074\/jbc.274.41.28909","article-title":"Subunit interactions in the clathrin-coated vesicle vacuolar (H(+))-ATPase complex","volume":"274","author":"Forgac","year":"1999","journal-title":"J Biol Chem"},{"key":"5","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1038\/nature14365","article-title":"Electron cryomicroscopy observation of rotational states in a eukaryotic V-ATPase","volume":"521","author":"Rubinstein","year":"2015","journal-title":"Nature"},{"key":"6","doi-asserted-by":"crossref","first-page":"17025","DOI":"10.1016\/S0021-9258(17)46944-4","article-title":"Disassembly and reassembly of the yeast vacuolar H(+)-ATPase in vivo","volume":"270","author":"Kane","year":"1995","journal-title":"J Biol Chem"},{"key":"7","doi-asserted-by":"crossref","first-page":"21761","DOI":"10.1074\/jbc.M002305200","article-title":"The H subunit (Vma13p) of the yeast V-ATPase inhibits the ATPase activity of cytosolic V1 complexes","volume":"275","author":"Kane","year":"2000","journal-title":"J Biol Chem"},{"key":"8","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.oraloncology.2007.02.011","article-title":"Intracellular pH regulation in oral squamous cell carcinoma is mediated by increased V-ATPase activity via over-expression of the ATP6V1C1 gene","volume":"44","author":"Garc\u00eda-Garc\u00eda","year":"2008","journal-title":"Oral Oncol"},{"key":"9","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1152\/physrev.00035.2015","article-title":"The Function of V-ATPases in Cancer","volume":"96","author":"Forgac","year":"2016","journal-title":"Physiol Rev"},{"key":"10","doi-asserted-by":"crossref","first-page":"C1015","DOI":"10.1152\/ajpcell.1993.265.4.C1015","article-title":"Vacuolar-type H(+)-ATPases are functionally expressed in plasma membranes of human tumor cells","volume":"265","author":"Gillies","year":"1993","journal-title":"Am J Physiol"},{"key":"11","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1002\/(SICI)1097-4652(199807)176:1<196::AID-JCP21>3.0.CO;2-4","article-title":"Distinct regulation of pHin and [Ca2+]in in human melanoma cells with different metastatic potential","volume":"176","author":"Gillies","year":"1998","journal-title":"J Cell Physiol"},{"key":"12","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/S0006-2952(99)00022-2","article-title":"pH and drug resistance. I. Functional expression of plasmalemmal V-type H+-ATPase in drug-resistant human breast carcinoma cell lines","volume":"57","author":"Gillies","year":"1999","journal-title":"Biochem Pharmacol"},{"key":"13","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1385\/CBB:40:2:185","article-title":"Plasmalemmal vacuolar-type H+-ATPase in cancer biology","volume":"40","author":"Mart\u00ednez-Zaguil\u00e1n","year":"2004","journal-title":"Cell Biochem Biophys"},{"key":"14","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1177\/00220345010800011001","article-title":"Interferon-gamma down-regulates gene expression of cathepsin K in osteoclasts and inhibits osteoclast formation","volume":"80","author":"Li","year":"2001","journal-title":"J Dent Res"},{"key":"15","first-page":"6517","article-title":"Pericellular pH affects distribution and secretion of cathepsin B in malignant cells","volume":"54","author":"Sloane","year":"1994","journal-title":"Cancer Res"},{"key":"16","first-page":"271","article-title":"Mechanisms in the skeletal complications of breast cancer","volume":"7","author":"Moseley","year":"2000","journal-title":"Endocr Relat Cancer"},{"key":"17","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1093\/hmg\/ddl474","article-title":"Novel pycnodysostosis mouse model uncovers cathepsin K function as a potential regulator of osteoclast apoptosis and senescence","volume":"16","author":"Li","year":"2007","journal-title":"Hum Mol Genet"},{"key":"18","doi-asserted-by":"crossref","first-page":"e58599","DOI":"10.1371\/journal.pone.0058599","article-title":"RNAi-mediated silencing of Atp6i and Atp6i haploinsufficiency prevents both bone loss and inflammation in a mouse model of periodontal disease","volume":"8","author":"Li","year":"2013","journal-title":"PLoS One"},{"key":"19","doi-asserted-by":"publisher","first-page":"46142","DOI":"10.18632\/oncotarget.10063","article-title":"The a3 isoform of subunit a of the vacuolar ATPase localizes to the plasma membrane of invasive breast tumor cells and is overexpressed in human breast cancer","volume":"7","author":"Forgac","year":"2016","journal-title":"Oncotarget"},{"key":"20","doi-asserted-by":"crossref","first-page":"16400","DOI":"10.1074\/jbc.M901201200","article-title":"Function of a subunit isoforms of the V-ATPase in pH homeostasis and in vitro invasion of MDA-MB231 human breast cancer cells","volume":"284","author":"Forgac","year":"2009","journal-title":"J Biol Chem"},{"key":"21","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.18632\/oncotarget.1699","article-title":"Inhibition of the vacuolar ATPase induces Bnip3-dependent death of cancer cells and a reduction in tumor burden and metastasis","volume":"5","author":"Webster","year":"2014","journal-title":"Oncotarget"},{"key":"22","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1124\/mol.106.028076","article-title":"Bafilomycin induces the p21-mediated growth inhibition of cancer cells under hypoxic conditions by expressing hypoxia-inducible factor-1alpha","volume":"70","author":"Chun","year":"2006","journal-title":"Mol Pharmacol"},{"key":"23","doi-asserted-by":"crossref","first-page":"5408","DOI":"10.1158\/0008-5472.CAN-06-4095","article-title":"Proton pump inhibitors induce apoptosis of human B-cell tumors through a caspase-independent mechanism involving reactive oxygen species","volume":"67","author":"Fais","year":"2007","journal-title":"Cancer Res"},{"key":"24","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1161\/01.RES.82.11.1139","article-title":"Effect of vacuolar proton ATPase on pHi, Ca2+, and apoptosis in neonatal cardiomyocytes during metabolic inhibition\/recovery","volume":"82","author":"Gottlieb","year":"1998","journal-title":"Circ Res"},{"key":"25","first-page":"3065","article-title":"Inhibition of mTORC1 leads to MAPK pathway activation through a PI3K-dependent feedback loop in human cancer","volume":"118","author":"Cantley","year":"2008","journal-title":"J Clin Invest"},{"key":"26","first-page":"3435","article-title":"The mTOR inhibitor everolimus in combination with carboplatin in metastatic breast cancer\u2014a phase I trial","volume":"32","author":"Eucker","year":"2012","journal-title":"Anticancer Res"},{"key":"27","doi-asserted-by":"crossref","first-page":"196ra99","DOI":"10.1126\/scitranslmed.3005747","article-title":"mTORC1 inhibition is required for sensitivity to PI3K p110\u03b1 inhibitors in PIK3CA-mutant breast cancer","volume":"5","author":"Hazra","year":"2013","journal-title":"Sci Transl Med"},{"key":"28","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1126\/science.1207056","article-title":"mTORC1 senses lysosomal amino acids through an inside-out mechanism that requires the vacuolar H(+)-ATPase","volume":"334","author":"Sabatini","year":"2011","journal-title":"Science"},{"key":"29","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.cell.2012.03.017","article-title":"mTOR signaling in growth control and disease","volume":"149","author":"Sabatini","year":"2012","journal-title":"Cell"},{"key":"30","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1101\/gad.1212704","article-title":"Upstream and downstream of mTOR","volume":"18","author":"Sonenberg","year":"2004","journal-title":"Genes Dev"},{"key":"31","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0092-8674(02)00808-5","article-title":"mTOR interacts with raptor to form a nutrient-sensitive complex that signals to the cell growth machinery","volume":"110","author":"Sabatini","year":"2002","journal-title":"Cell"},{"key":"32","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1016\/j.cub.2006.08.001","article-title":"mSin1 is necessary for Akt\/PKB phosphorylation, and its isoforms define three distinct mTORC2s","volume":"16","author":"Sabatini","year":"2006","journal-title":"Curr Biol"},{"key":"33","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1016\/j.cub.2004.06.054","article-title":"Rictor, a novel binding partner of mTOR, defines a rapamycin-insensitive and raptor-independent pathway that regulates the cytoskeleton","volume":"14","author":"Sabatini","year":"2004","journal-title":"Curr Biol"},{"key":"34","doi-asserted-by":"crossref","first-page":"1942","DOI":"10.1126\/science.1066015","article-title":"Phosphatidic acid-mediated mitogenic activation of mTOR signaling","volume":"294","author":"Chen","year":"2001","journal-title":"Science"},{"key":"35","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/nature10912","article-title":"The translational landscape of mTOR signalling steers cancer initiation and metastasis","volume":"485","author":"Martin","year":"2012","journal-title":"Nature"},{"key":"36","doi-asserted-by":"crossref","first-page":"5314","DOI":"10.1200\/JCO.2005.66.130","article-title":"Phase II study of temsirolimus (CCI-779), a novel inhibitor of mTOR, in heavily pretreated patients with locally advanced or metastatic breast cancer","volume":"23","author":"Ostapenko","year":"2005","journal-title":"J Clin Oncol"},{"key":"37","doi-asserted-by":"crossref","first-page":"3077","DOI":"10.1158\/0008-5472.CAN-07-3293","article-title":"Oncogene addiction","volume":"68","author":"Felsher","year":"2008","journal-title":"Cancer Res"},{"key":"38","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1158\/2159-8290.CD-12-0095","article-title":"The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data","volume":"2","author":"Goldberg","year":"2012","journal-title":"Cancer Discov"},{"key":"39","first-page":"l1","article-title":"Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal","volume":"6","author":"Schultz","year":"2013","journal-title":"Sci Signal"},{"key":"40","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1186\/1471-2407-14-970","article-title":"PROGgeneV2: enhancements on the existing database","volume":"14","author":"Nakshatri","year":"2014","journal-title":"BMC Cancer"},{"key":"41","doi-asserted-by":"crossref","first-page":"R953","DOI":"10.1186\/bcr1325","article-title":"Gene expression profiling spares early breast cancer patients from adjuvant therapy: derived and validated in two population-based cohorts","volume":"7","author":"Nordgren","year":"2005","journal-title":"Breast Cancer Res"},{"key":"42","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1093\/jnci\/djj052","article-title":"Gene expression profiling in breast cancer: understanding the molecular basis of histologic grade to improve prognosis","volume":"98","author":"Cardoso","year":"2006","journal-title":"J Natl Cancer Inst"},{"key":"43","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1042\/BJ20081073","article-title":"Atp6v1c1 is an essential component of the osteoclast proton pump and in F-actin ring formation in osteoclasts","volume":"417","author":"Li","year":"2009","journal-title":"Biochem J"},{"key":"44","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1038\/70563","article-title":"Atp6i-deficient mice exhibit severe osteopetrosis due to loss of osteoclast-mediated extracellular acidification","volume":"23","author":"Stashenko","year":"1999","journal-title":"Nat Genet"},{"key":"45","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/S1476-5586(03)80037-4","article-title":"Extracellular acidification alters lysosomal trafficking in human breast cancer cells","volume":"5","author":"Bhujwalla","year":"2003","journal-title":"Neoplasia"},{"key":"46","doi-asserted-by":"crossref","first-page":"3680","DOI":"10.1074\/jbc.M114.611210","article-title":"Activity of plasma membrane V-ATPases is critical for the invasion of MDA-MB231 breast cancer cells","volume":"290","author":"Forgac","year":"2015","journal-title":"J Biol Chem"},{"key":"47","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1038\/nrc867","article-title":"Metastasis to bone: causes, consequences and therapeutic opportunities","volume":"2","author":"Mundy","year":"2002","journal-title":"Nat Rev Cancer"},{"key":"48","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.ccr.2004.06.007","article-title":"The LKB1 tumor suppressor negatively regulates mTOR signaling","volume":"6","author":"Cantley","year":"2004","journal-title":"Cancer Cell"},{"key":"49","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.ccr.2006.10.008","article-title":"A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes","volume":"10","author":"DeVries","year":"2006","journal-title":"Cancer Cell"},{"key":"50","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s10549-006-9392-8","article-title":"MDA-MB-435 cells are derived from M14 melanoma cells\u2014a loss for breast cancer, but a boon for melanoma research","volume":"104","author":"Johnson","year":"2007","journal-title":"Breast Cancer Res Treat"},{"key":"51","doi-asserted-by":"crossref","first-page":"853","DOI":"10.7150\/ijbs.6030","article-title":"Silencing of atp6v1c1 prevents breast cancer growth and bone metastasis","volume":"9","author":"Chen","year":"2013","journal-title":"Int J Biol Sci"},{"key":"52","doi-asserted-by":"crossref","first-page":"7893","DOI":"10.1158\/0008-5472.CAN-09-2396","article-title":"Comment Re: MDA-MB-435 and M14 cell lines: identical but not M14 Melanoma?","volume":"69","author":"Schutte","year":"2009","journal-title":"Cancer Res"},{"key":"53","doi-asserted-by":"crossref","first-page":"5292","DOI":"10.1158\/0008-5472.CAN-09-1528","article-title":"MDA-MB-435 and M14 cell lines: identical but not M14 melanoma?","volume":"69","author":"Chambers","year":"2009","journal-title":"Cancer Res"},{"key":"54","first-page":"142","article-title":"Recovery of a cell surface fetal antigen from circulating immune complexes of melanoma patients","volume":"27","author":"Morton","year":"1988","journal-title":"Cancer Immunol Immunother"},{"key":"55","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1007\/s10585-004-3759-1","article-title":"Common origins of MDA-MB-435 cells from various sources with those shown to have melanoma properties","volume":"21","author":"Thompson","year":"2004","journal-title":"Clin Exp Metastasis"},{"key":"56","doi-asserted-by":"crossref","first-page":"10106","DOI":"10.1158\/0008-5472.CAN-07-1362","article-title":"2-Methoxyestradiol suppresses osteolytic breast cancer tumor progression in vivo","volume":"67","author":"Oursler","year":"2007","journal-title":"Cancer Res"},{"key":"57","first-page":"159","article-title":"Molecular mechanisms of tumor-bone interactions in osteolytic metastases","volume":"10","author":"Guise","year":"2000","journal-title":"Crit Rev Eukaryot Gene Expr"},{"key":"58","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1261\/rna.2192803","article-title":"Lentivirus-delivered stable gene silencing by RNAi in primary cells","volume":"9","author":"Novina","year":"2003","journal-title":"RNA"},{"key":"59","doi-asserted-by":"crossref","first-page":"3362","DOI":"10.1242\/jcs.008300","article-title":"Specificity of RGS10A as a key component in the RANKL signaling mechanism for osteoclast differentiation","volume":"120","author":"Li","year":"2007","journal-title":"J Cell Sci"},{"key":"60","first-page":"4148","volume-title":"Current protocol in immunology","author":"Coicor","year":"1991"},{"key":"61","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1111\/j.1755-148X.2009.00545.x","article-title":"Lentivirus-mediated bifunctional cell labeling for in vivo melanoma study","volume":"22","author":"Merlino","year":"2009","journal-title":"Pigment Cell Melanoma Res"},{"key":"62","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1002\/jcp.21576","article-title":"Targeted overexpression of BSP in osteoclasts promotes bone metastasis of breast cancer cells","volume":"218","author":"Chen","year":"2009","journal-title":"J Cell Physiol"},{"key":"63","doi-asserted-by":"crossref","first-page":"6843","DOI":"10.1158\/0008-5472.CAN-04-3822","article-title":"The growth and metastasis of human hepatocellular carcinoma xenografts are inhibited by small interfering RNA targeting to the subunit ATP6L of proton pump","volume":"65","author":"Yang","year":"2005","journal-title":"Cancer Res"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.17544","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,28]],"date-time":"2022-07-28T03:28:30Z","timestamp":1658978910000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.17544"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5,2]]},"references-count":63,"journal-issue":{"issue":"29","published-print":{"date-parts":[[2017,7,18]]}},"alternative-id":["17544","28504970"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.17544","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,5,2]]}}}